Valuation: Repligen Corporation

Market Cap 998.52Cr 891.67Cr 823.74Cr 746.49Cr 1.4TCr 95TCr 1.42TCr 9.91TCr 3.92TCr 50TCr 3.75TCr 3.67TCr 1,56600Cr P/E 2026 *
255x
P/E 2027 * 105x
Enterprise Value 995.7Cr 889.16Cr 821.41Cr 744.38Cr 1.39TCr 95TCr 1.42TCr 9.88TCr 3.91TCr 50TCr 3.74TCr 3.66TCr 1,56100Cr EV / Sales 2026 *
11.9x
EV / Sales 2027 * 9.1x
Free-Float
94.95%
Yield 2026 *
-
Yield 2027 * -
1 day-1.00%
1 week+0.86%
Current month-7.96%
1 month-4.12%
3 months+28.58%
6 months+55.12%
Current year+7.98%
1 week 172
Extreme 172
185.02
1 month 157.44
Extreme 157.4355
198.87
Current year 100.99
Extreme 100.99
198.87
1 year 100.99
Extreme 100.99
198.87
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
306.98
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Director/Board Member 61 01/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
06/10/26 Free

Executive/Senior Manager

1,375 0.0024%
05/10/26 Sell

Chief Executive Officer

-13,939 0.0247%
02/10/26 Tax

Chief Executive Officer

-1,248 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-1.00%+0.86%+7.10%+23.06% 998.52Cr
+1.16%-1.13%-17.92%+8.27% 18TCr
+0.02%+4.24%-19.82%+16.53% 12TCr
-1.22%+0.70%+1.27%+31.80% 12TCr
+2.29%+17.36%-41.94%+9.49% 9.33TCr
-2.21%-2.91%+0.74%+75.30% 6.32TCr
-1.06%+1.75%+13.50%+80.00% 5.57TCr
-0.75%+3.73%+6.64%-22.28% 5.42TCr
-1.13%+0.00%-12.25%+31.02% 4.41TCr
+0.17%+5.85%-4.92%-10.64% 3.4TCr
Average -0.37%+3.33%-6.76%+24.25% 7.68TCr
Weighted average by Cap. -0.02%+3.06%-11.44%+22.48%

Financials

2026 *2027 *
Net sales 84Cr 75Cr 69Cr 63Cr 116.97Cr 7.94TCr 118.9Cr 830.21Cr 328.69Cr 4.16TCr 313.85Cr 307.18Cr 13TCr 108Cr 96Cr 89Cr 81Cr 151.05Cr 10TCr 153.55Cr 1.07TCr 424.47Cr 5.37TCr 405.31Cr 396.69Cr 17TCr
Net income 3.99Cr 3.56Cr 3.29Cr 2.98Cr 5.58Cr 378.79Cr 5.67Cr 40Cr 16Cr 198.46Cr 15Cr 15Cr 625.69Cr 11Cr 9.64Cr 8.91Cr 8.07Cr 15Cr 1.02TCr 15Cr 107.18Cr 42Cr 536.97Cr 41Cr 40Cr 1.69TCr
Net Debt -2.82Cr -2.52Cr -2.33Cr -2.11Cr -3.94Cr -267.55Cr -4.01Cr -28Cr -11Cr -140.18Cr -11Cr -10Cr -441.95Cr -16Cr -14Cr -13Cr -12Cr -22Cr -1.49TCr -22Cr -155.71Cr -62Cr -780.14Cr -59Cr -58Cr -2.46TCr
Projected Income Statement - Annual - Repligen Corporation
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
23/26/23 $176.93 -1.00% 10,66,119
22/26/22 $178.71 -0.72% 12,72,487
21/26/21 $180.01 +0.63% 9,03,860
20/26/20 $178.88 +1.39% 8,77,749
19/26/19 $176.43 +0.58% 7,69,102
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Repligen Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
176.93USD
Average target price
201.45USD
Spread / Average Target
+13.86%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Repligen Corporation
  1. Stock Market
  2. Stocks
  3. RGEN Stock